Olivia MillerWillie Nelson, 93, is currently mid-tour across North America — performing 18 confirmed dates between April and August 2026, including the Outlaw Music Festival's 12-city run — despite living with emphysema, a progressive lung disease that has forced significant changes to how the country legend performs. His story has sparked renewed interest in how Australians living with chronic obstructive pulmonary disease, or COPD, can maintain quality of life as the condition advances.
A Legend Who Refuses to Stop
Born on 29 April 1933, Willie Nelson turned 93 this year. He released his new studio album "Dream Chaser" on 29 May 2026 and headlined the Luck Reunion at his Spicewood, Texas ranch during SXSW in March. Every show now features his son Lukas Nelson sharing vocal duties to protect Willie's stamina, and performances are conducted seated. His tour bus carries a nebulizer — a device that converts liquid medication into a mist for inhalation — and his schedule includes built-in rest days between performances.
Nelson stopped smoking tobacco years ago. He now manages his symptoms with a THC-infused tonic he and his wife Annie D'Angelo helped develop, alongside conventional respiratory treatment. He has also dismissed a wave of AI-generated hoaxes circulating on social media falsely claiming he had been hospitalised, calling them "a joke."
His determination to keep performing at 93 with active emphysema raises a question relevant to the estimated 500,000 Australians currently living with COPD: what does responsible management of this disease actually look like — and when is it time to consult a respiratory specialist?
What Is Emphysema, and Why Does It Progress?
Emphysema is a form of COPD in which the air sacs in the lungs (alveoli) are gradually destroyed, reducing the surface area available for oxygen exchange. The damage is permanent — it cannot be reversed. What can be managed is the rate at which the disease progresses and the severity of symptoms at each stage.
The most common cause in Australia is long-term tobacco smoking. According to the Lung Foundation Australia, COPD is the fifth leading cause of death in Australia and affects an estimated 1 in 13 Australians aged 40 and over — though many cases remain undiagnosed for years because the early symptoms are mild or dismissed as a normal part of ageing.
The disease typically progresses through four stages — mild, moderate, severe and very severe — with breathlessness, chronic cough, and increased susceptibility to respiratory infections worsening at each stage. What makes emphysema particularly insidious is that most patients have already lost 50 per cent or more of their lung function by the time they receive a formal diagnosis.
The Three Warning Signs Australians Should Not Ignore
Respiratory specialists consistently flag three symptoms that signal it is time to stop managing at home and seek formal medical assessment.
Shortness of breath during activities you once handled easily. If climbing a single flight of stairs, walking to the letterbox, or carrying shopping bags now leaves you noticeably winded, this is not a sign of normal ageing. It is a symptom warranting spirometry testing — a simple, non-invasive breathing test that can assess lung function and detect COPD in its earlier stages, when management is most effective.
A cough that has lasted more than eight weeks. A persistent cough, especially one that produces mucus, is one of the earliest warning signs of COPD in Australia's primary care setting. Many patients attribute it to seasonal allergies or a slow recovery from a cold. A cough lasting more than two months without explanation should be formally investigated.
Frequent chest infections. COPD compromises the lungs' ability to clear mucus and fight off bacterial or viral infection. Patients with undiagnosed or poorly managed emphysema often experience two or more chest infections per year before they seek specialist help. Each infection can permanently accelerate lung damage.
Managing COPD in 2026: What Works
The management strategies Willie Nelson has adopted — ceasing smoking, using a nebulizer, pacing activity, relying on support from family members — are broadly consistent with evidence-based COPD management, though cannabis's role in respiratory care remains subject to ongoing research and is not a recommended first-line therapy.
For Australians, the recommended toolkit for managing emphysema includes:
Pulmonary rehabilitation. A structured exercise program supervised by physiotherapists and respiratory nurses, pulmonary rehabilitation has been shown in Australian clinical trials to reduce hospital admissions, improve exercise capacity, and significantly improve quality of life in COPD patients. It is funded through public hospitals in most states.
Maintenance medication. Long-acting bronchodilators, including LABA and LAMA inhalers, are the cornerstone of COPD treatment. They open the airways and reduce the frequency of acute exacerbations. Combination inhaler therapy is now standard for moderate-to-severe disease.
Vaccination. Annual influenza vaccination and five-yearly pneumococcal vaccination are strongly recommended for COPD patients, as respiratory infections are the leading cause of acute exacerbations that accelerate lung damage.
Oxygen therapy. At the severe stage, many patients benefit from supplemental oxygen at home. In Australia, this is assessed through an arterial blood gas test and is available through state-funded home oxygen programs.
When to Call a Respiratory Specialist
Many Australians with mild-to-moderate COPD manage their condition through their general practitioner. However, certain situations warrant direct referral to a respiratory physician or pulmonologist.
These include: a first formal COPD diagnosis (to confirm staging and establish a baseline management plan), any single hospitalisation for an acute exacerbation, symptoms that worsen despite optimal inhaler therapy, and any situation where oxygen therapy is being considered.
A respiratory specialist can arrange comprehensive pulmonary function testing, recommend targeted pulmonary rehabilitation programs, and — in appropriate cases — assess eligibility for newer interventional treatments such as bronchoscopic lung volume reduction, which can improve lung function in patients with severe emphysema who have not responded well to medication.
Willie Nelson's Lesson for Australians With Lung Disease
Willie Nelson's touring schedule is extraordinary for a person of any age, let alone one of 93 with a chronic lung condition. But his ability to perform in 2026 is not accidental — it reflects decades of careful adaptation: stopping smoking, adjusting performance conditions, managing stamina, and accepting support. Those adjustments began long before the disease reached its most severe stage.
For Australians living with emphysema or COPD, the same principle applies. Early intervention, regular specialist review, and honest conversations with your GP about symptoms that seem mild are the factors that determine whether COPD remains manageable or becomes disabling. The concert may look effortless from the audience. The preparation behind it rarely is.
This article is for general informational purposes only and does not constitute medical advice. If you are experiencing respiratory symptoms, please consult a qualified health professional.
